Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government-funding notice along with the prior revision entry v3.4.1 were removed; these are minor boilerplate updates that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:02.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice indicating government funding issues and ongoing operations; Updated the page revision from v3.4.0 to v3.4.1. These changes are minor and do not affect study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:50.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle to the page. Updated metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and bumped the revision to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:53:11.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has removed the Statistical Analysis Plan and Study Protocol documents (and accompanying metadata) from Study Documents. Additionally, related notes about IPD sharing and FDA-regulated status were removed, reducing access to critical study details.
    Difference
    17%
    Check dated 2026-01-21T04:51:59.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision bumped from v3.3.3 to v3.3.4. No user-facing content changes observed on the Study Details page.
    Difference
    0.1%
    Check dated 2026-01-14T03:16:41.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Locations section updated to include California, Maryland, Massachusetts, Nevada, Pennsylvania, Tennessee, and Texas, and the revision note updated to v3.3.3 (replacing v3.3.2).
    Difference
    0.9%
    Check dated 2025-12-23T17:31:29.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.